38140
CAISMOV24, a new human ovarian carcinoma cell line
In the present study, we report the establishment of a new human ovarian carcinoma cell line. In vitro culture was established with cells from ascites of a patient with recurrent ovarian cancer. CAISMOV24 cell line was characterized in regard to cell growth, production of CA125 and expression of cell surface molecules HLA-class I CD155 and CD326. This new ovarian cell line resembles its cognate type 2 serous carcinoma.